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Background: To evaluate the feasibility of echocardiography after transcatheter 
closure of patent ductus arteriosus (PDA) with coils.
Methods: Between April 1998 and December 2006, 131 patients had transcatheter coil 
occlusion of their PDA using Gianturco coils. We hypothesized that post-procedural 
hemolysis would not occur if a residual shunt < 1 mm or if no continuous waveform 
was detected by echocardiography. Immediately after coil implantation, patients 
without and with a residual shunt as detected by echocardiography were desig-
nated to groups A and B, respectively. The clinical presentations, laboratory data 
and outcomes were compared between the two groups.
Results: There were 101 patients in group A and 30 patients in group B. Patients in 
group B had larger ductal diameter (2.8 ± 0.9 mm vs. 1.6 ± 0.8 mm; p < 0.001), larger 
Qp/Qs (1.9 ± 0.9 vs. 1.3 ± 0.4; p = 0.001), higher frequency of more than one coil 
used (14/30 vs. 11/101; p < 0.001), and female predominance (22/30 vs. 53/101; 
p = 0.043) compared with group A. Trivial residual shunt was noted in 6 patients in 
group A and 20 patients in group B on the day after embolization. All shunts sponta-
neously closed within 6 months in patients of group A, while five patients in group B 
had a persistent shunt at the 1-year follow-up and thereafter. Although the patients 
in group B had higher residual shunt rate than group A during follow-up (p < 0.001), 
none of these patients suffered from hemolysis.
Conclusion: Echocardiography is a feasible tool to assess residual shunt after PDA 
closure. If a residual shunt < 1 mm or if no continuous waveform is detected by 
echocardiography, the risk of developing hemolysis is low.
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1.  Introduction
Since the first transcatheter closure of patent duc-
tus arteriosus (PDA) using Gianturco coils was re-
ported by Cambier et al in 1992,1 the procedure 
has gained increasing popularity worldwide. The 
technique is simple, involving a small delivery cath-
eter, low cost, and has a high success rate. However, 
the method carries some risks for complications, 
and post-procedural hemolysis is one of the most 
serious of such complications.2,3
To our knowledge, there is currently no method 
that prevents hemolysis. The use of echocardiog-
raphy for patients who receive transcatheter clo-
sure of PDA in the catheterization laboratory has 
proved to be a valuable method.4 The objective of 
this study was to evaluate the feasibility of using 
echocardiography to assess residual shunt, and to 
design a strategy that prevents hemolysis after tran-
scatheter closure of PDA with coils.
2.  Materials and Methods
Between April 1998 and December 2006, 171 pa-
tients with PDA were referred to our institution for 
transcatheter closure. Of these, 131 patients were 
included in this study and successfully managed 
with Gianturco coils (Cook Cardiology, Bloomington, 
IN, USA). A total of 40 patients were excluded. Of 
these, 33 patients had PDA (> 4 mm) and/or associ-
ated with pulmonary hypertension; 26 of the 33 
patients were referred to surgical ligation, and 7 
of the 33 were managed with Amplatzer duct oc-
cluder. The remaining seven patients with ductal 
diameter < 1 mm, which precluded transcatheter 
closure were also excluded from study.
Informed consent was obtained from the pa-
tients’ parents. The study was approved by the 
human investigation committee of our institutional 
review board. All procedures were performed under 
local anesthesia. Patients 6 years of age or less were 
sedated with intravenous ketamine or diazepam. 
All patients received prophylactic antibiotic treat-
ment with one dose of cefazolin (25 mg/kg) given 
intravenously. Prior to the attempted occlusion, the 
minimal PDA diameter was measured by aortogra-
phy. The diameter of the implanted coil was at 
least 1.7 times the minimum PDA diameter and the 
length of the coil was sufficient to produce four or 
five loops.
All patients underwent transthoracic echocar-
diography within 15 minutes after transcatheter 
deployment of the coils in the catheterization lab-
oratory. Echocardiography was performed using 
the Philips SONOS 5500 or 7500 system (Philips, 
Andover, MA, USA) and 5 MHz to 8 MHz transducers. 
The presence of a residual shunt was evaluated by 
echocardiography with color flow Doppler in the 
parasternal short-axis view. The width of the re-
sidual shunt was measured at the junction of the 
PDA and the pulmonary artery by color Doppler 
(Figure 1). The waveform of the residual shunt was 
determined by continuous-wave Doppler. Aortogra-
phy was performed at the end of the procedure as 
a control for comparison with echocardiography.
We hypothesized that post-procedural hemolysis 
would not occur if a residual PDA shunt of < 1 mm or 
if no continuous waveform was detected by echocar-
diography. The number of coils used in the procedure 
was determined by the operator based on the ductal 
diameter and personal experience. Immedi ately 
after coil implantation, patients without and with a 
residual shunt as detected by echocardiography were 
designated to groups A and B, respectively. Group B 
was further subdivided as residual shunt < 1 mm or no 
continuous waveform, and residual shunt ≥ 1 mm or 
with continuous waveform. For all patients in group 
A, and for patients in group B who had a residual 
shunt < 1 mm or no continuous waveform, we did not 
use more coils in the catheterization laboratory. In 
patients in group B with a residual shunt ≥ 1 mm, or 
with a continuous waveform on echocardiography, 
additional coils were implanted until one of the fol-
lowing conditions was fulfilled: no residual shunt, re-
sidual shunt < 1 mm, or no continuous waveform 
shunt detected by echocardiography. Follow-up 
echocardiography was performed the next day, at 3, 
6 and 12 months after the procedure, and annually 
thereafter. Inspection of patients’ urine and skin 
color was done to detect the presence of hemolysis.
Results are expressed as means ± standard devi-
ation for continuous variables or as the number of 
Figure 1 Immediately after coil implantation, a tiny 
jet (arrow) was visualized by color Doppler in the par-
asternal short-axis view. The residual shunt had sponta-
neously closed at 3-month follow-up.
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cases and percentages for categorical variables. 
Comparisons between groups were done with un-
paired Student’s t test for continuous variables, 
and χ2 test and Fisher’s exact test for categorical 
variables. Statistical analysis was performed using 
SPSS (SPSS Inc., Chicago, IL, USA). A p value < 0.05 
was considered statistically significant.
3.  Results
A total of 131 patients underwent successful coil 
implantation in our study. The age of patients ranged 
from 4 months to 18 years (mean, 3.0 ± 3.7 years). 
The body weight ranged from 5.4 kg to 63.0 kg 
(mean, 13.9 ± 9.0 kg). Based on Doppler echocardi-
ographic findings, 101 patients were allocated to 
group A and 30 patients to group B. The immediate 
residual shunt was 22.9% (30/131). The clinical data 
and outcomes of groups A and B are summarized in 
Table 1. In group A, 90 patients had one coil and 11 
patients had two coils implanted. In group B, 16 
patients had one coil, and 14 patients required two 
or three coils to achieve the criteria of a residual 
shunt < 1 mm or no continuous waveform detected 
before leaving the catheterization laboratory.
Patients in group B had bigger PDA diameter 
(2.8 ± 0.9 mm vs. 1.6 ± 0.8 mm; p < 0.001), larger Qp/
Qs (1.9 ± 0.9 vs. 1.3 ± 0.4; p = 0.001) and higher fre-
quency of more than one coil used (14/30 vs. 11/101; 
p < 0.001) than patients in group A. There were more 
female than male patients in group B compared 
with those of group A (22/30 vs. 53/101; p = 0.043). 
There were no statistically significant differences 
between both groups in terms of age (p = 0.764), 
body weight (p = 0.775) and duration of follow-up 
(p = 0.325). The sensitivity for detecting residual 
shunt was 77.1% and 72.5% for echocardiography and 
aortography, respectively. The results of the resid-
ual PDA shunt are summarized in Table 2. PDA re-
canalization was noted in six patients in group A on 
the first post-procedural day. All of these residual 
shunts spontaneously closed within 6 months of 
follow-up. Twenty patients in group B had a resid-
ual shunt on the first post-procedural day. Sponta-
neous closure of the residual shunts occurred in 
15 patients within 6 months, while five patients had 
a trivial shunt at 1 year follow-up, which remained 
thereafter. Although the residual shunt rate was 
higher in group B than in group A during the follow-
up period (Table 2, p < 0.001), none of these pa-
tients suffered from hemolysis.
4.  Discussion
The potential causes of morbidity after transcath-
eter closure of PDA include device embolization, ob-
struction of the pulmonary arteries or the thoracic 
aorta, persisting residual shunt and hemolysis. Device 
embolization, obstruction of the great vessels or 
malposition can be recognized and easily managed 
by an experienced cardiologist in the catheteriza-
tion laboratory. However, post-procedural intra-
vascular hemolysis due to insufficient PDA closure 
remains problematic and unpredictable.
Angiography is regarded as the gold standard to 
assess residual shunts after transcatheter PDA clo-
sure. Angiography allows for evaluation of the device 
position, residual leak and the need for implanta-
tion of additional coils. Zellers et al5 recommended 
that patients should leave the catheterization lab-
oratory without any residual shunt to prevent hemo-
lysis. However, immediate residual shunt is very 
Table 1 Clinical manifestations of patent ductus arteriosus after transcatheter coil embolization
 Patients with no residual Patients with residual 
p
 
 shunt (n =101) shunt (n = 30) 
Age (yr) 3.1 ± 3.7 2.8 ± 3.9 0.764
Sex (males/females) 48/53 8/22 0.043*
Body weight (kg) 14.0 ± 8.9 13.5 ± 9.2 0.775
Arterial duct diameter 1.6 ± 0.8 2.8 ± 0.9 < 0.001*
Qp/Qs 1.3 ± 0.4 1.9 ± 0.9 0.001*
More than one coil used 11/101 14/30 < 0.01*
Follow-up (yr) 4.6 ± 2.3 5.1 ± 2.2 0.325
*p < 0.05. Qp = pulmonary blood flow; Qs = systemic blood flow.
Table 2  Patients with residual shunt detected by 
Doppler echocardiography
Time after Group A Group B 
p
 
procedure (n = 101) (n = 30) 
1 d 6/101 20/30 < 0.001
3 mo 1/101 12/30 < 0.001
6 mo 0/101 5/30 < 0.001
12 mo 0/101 5/30 < 0.001
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common, with an incidence ranging from 32% to 
42% in published series.5−7 Although the majority 
of patients with residual shunts are classified as 
silent PDA and spontaneous closure of these PDA 
might occur within 3−6 months, Shim et al7 reported 
that 7% of patients with residual PDA will require a 
second procedure to close the shunt. Therefore, 
predicting the clinical outcome of residual shunt 
based on angiography remains defective.
Hemolysis after PDA closure by coils is due to a 
residual shunt with high velocity flow through the 
implanted device, leading to mechanical destruc-
tion of the erythrocytes. The reported incidence 
of hemolysis ranged from 1.0% to 3.6%.2,8,9 For PDA 
with a diameter > 3 mm, the incidence is up to 
18.8%.10 The reported risk factors for insufficient 
coil occlusion included large ductus, young age and 
a small ratio of the loop diameter to the ductal 
diameter.2,8 Hemolysis was typically noted within 
24 hours after the procedure but could also occur 
weeks to months after the intervention. Once hemo-
lysis has occurred, severe anemia or renal failure 
may follow.2 Remedial procedures include conserv-
ative treatment with blood transfusion, immediate 
deployment of an additional coil to close the re-
sidual leak, removal of the coils, or surgery.11,12 In 
our study, although patients in group B had larger 
PDA diameter than patients in group A, none of the 
patients with a residual shunt < 1 mm or no contin-
uous waveform detected developed hemolysis. Al-
though our strategy could not assure complete 
closure of the PDA all the time, the strategy effec-
tively prevented hemolysis.
In the Magee et al13 report of patients with 
Doppler color flow mapping for residual shunt, seven 
of the nine patients with a continuous high veloc-
ity residual shunt required treatment with a second 
device after a mean duration of 2 years, and the 
remaining two patients exhibited continuous flow 
during follow-up. By contrast, patients without a 
continuous flow jet are more likely to exhibit spon-
taneous closure.13 These results are in line with 
those of our study.
Echocardiography was recently reported as a 
useful tool for evaluating patients after transcath-
eter closure of PDA.4,7,13 In our study, according to 
the echocardiographic criteria for managing PDA 
patients in the catheterization laboratory, no pa-
tient suffered from hemolysis after transcatheter 
closure of PDA. In addition, there were two addi-
tional benefits observed in our study. First, for pa-
tients in group A, post-procedural angiography could 
be replaced by echocardiography because the re-
sults of the two studies were very similar. This would 
be beneficial in reducing radiation exposure and 
contrast dosage in these patients. Second, patients 
in group B with a residual shunt of < 1 mm or with no 
continuous waveform detected, no additional coils 
were required. This can decrease the number of 
coils implanted. Using fewer coils are advantageous, 
not only in shortening procedure and fluoroscopy 
time but also in reducing the risk of left pulmonary 
artery stenosis.14 In our study, most PDAs (81%, 
106/131) could be closed by one coil; none of the 
patients developed pulmonary artery stenosis.
The principal limitation of our study was that 
it was retrospective and nonrandomized. Most pa-
tients (104/131) had a ductus diameter of 3 mm 
or less. These patients had a lower risk of develop-
ing hemolysis compared with those with a large 
PDA (> 3 mm). Therefore, examining patients with 
a larger PDA will be valuable in evaluating and 
verifying the proposed echocardiography-guided 
management strategy. However, with immediate 
echocardiography after transcatheter closure of 
PDA, the criteria of a residual shunt < 1 mm or no 
continuous waveform detected by echocardiogra-
phy proved to be a good approach for preventing 
post-procedural hemolysis.
In conclusion, echocardiography is a feasible 
tool to assess residual shunt after PDA closure. If a 
residual shunt < 1 mm or no continuous waveform 
is detected by echocardiography, the risk of devel-
oping hemolysis is low.
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